- Home
- ASMB vs SNAL Comparison
ASMB vs SNAL Comparison
Compare ASMB & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASMB | SNAL |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 21.2M |
| IPO Year | 2010 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ASMB | SNAL |
|---|---|---|
| Price | $20.28 | $2.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $52.00 | N/A |
| AVG Volume (30 Days) | ★ 202.1K | 12.5K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 91.78 | ★ 120.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $81,225,622.00 |
| Revenue This Year | N/A | $22.50 |
| Revenue Next Year | N/A | $9.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.94 | $0.59 |
| 52 Week High | $39.71 | $21.60 |
Technical Indicators
Market Signals| Indicator | ASMB | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 31.31 | 47.78 |
| Support Level | N/A | $2.10 |
| Resistance Level | $30.36 | $2.70 |
| Average True Range (ATR) | 1.10 | 0.21 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 7.07 | 64.11 |
Price Performance
Historical ComparisonAbout ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.